These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5302100)

  • 21. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of cephalosporin C on Coombs' test (author's transl)].
    Seiga K; Minakawa M; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1974 Apr; 27(2):128-34. PubMed ID: 4546608
    [No Abstract]   [Full Text] [Related]  

  • 23. Cephalosporins.
    Can Med Assoc J; 1971 Jul; 105(1):9-10. PubMed ID: 5092516
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative evaluation of cefazolin and cephalothin in children.
    Pickering LK; O'Connor DM; Anderson D; Bairan AC; Feigin RD; Cherry JD
    J Pediatr; 1974 Dec; 85(6):842-7. PubMed ID: 4417819
    [No Abstract]   [Full Text] [Related]  

  • 25. Cephalothin and cephaloridine: comparative pharmacodynamics in chronic uremia.
    Perkins RL; Smith EJ; Saslaw S
    Am J Med Sci; 1969 Feb; 257(2):116-24. PubMed ID: 4974464
    [No Abstract]   [Full Text] [Related]  

  • 26. Cephalothin and cephaloridine: a re-evaluation of in vitro susceptibilities.
    Hinz W; Riley HD
    J Okla State Med Assoc; 1974 Mar; 67(3):95-101. PubMed ID: 4819922
    [No Abstract]   [Full Text] [Related]  

  • 27. The susceptibility of Clostridium perfringens type A to cephalosporin C antibiotics in vitro.
    Traub WH
    Chemotherapy; 1971; 16(1):11-7. PubMed ID: 4324251
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin].
    Kitamoto O; Fukaya K; Wajima T
    J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Sep; 42(9):1900-12. PubMed ID: 2810753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of antibacterial activity of cephapirin with cephalothin and cephaloridine to various pathogenic bacteria recently isolated from clinical materials (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1974 Apr; 27(2):157-63. PubMed ID: 4211361
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antistaphylococcic effect of cephalothin, cephaloridine and cephazoline. I. In vitro activity].
    Martinetto P; Savoia D; Cavallo G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):374-6. PubMed ID: 5155946
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of chronic destructive pneumonia with cephaloridine.
    Le Roux BT
    Postgrad Med J; 1970 Oct; ():Suppl:119-21. PubMed ID: 5488191
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-specific pneumopathies: clinical and laboratory trials of rifamide].
    de Barros LC; Hellmeister O; Lima GA
    Hospital (Rio J); 1966 Aug; 70(2):329-45. PubMed ID: 5300309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial activity of cephalothin].
    Goto S; Kuwabara S
    J Antibiot B; 1965 Dec; 18(6):439-42. PubMed ID: 5296406
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cephalothin in internal medicine, with special reference to the treatment of grave hospital infections].
    Altucci P; Varone G; Catalano G
    Clin Ter; 1970 Feb; 52(4):329-42. PubMed ID: 5527878
    [No Abstract]   [Full Text] [Related]  

  • 37. [The study of pharmacokinetics of antimicrobial agents in new born infants. I. Transition of serum concentration after intravenous administration of cephalosporin C analogues (author's transl)].
    Kurosu Y
    Jpn J Antibiot; 1979 Oct; 32(10):1009-16. PubMed ID: 513282
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of antibiotics on serum fibrinogen levels.
    Morrison JC; Ellis G; Jones T; Wiser WL; Whybrew WD; Bucovaz ET; Dugdale M; Fish SA
    Obstet Gynecol; 1973 Jul; 42(1):80-6. PubMed ID: 4720210
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infections of the genitourinary system. Treatment with cephalothin and cephaloridine].
    Evans JG
    Prensa Med Mex; 1969; 34(5):Suppl:78-83. PubMed ID: 5380778
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical studies on intravenous administration of cephalothin--evaluation of the clinical data before and after cephalothin injection].
    Takayasu H; Kishimoto T; Aso Y; Miyamura R; Koiso K
    Saishin Igaku; 1971 Apr; 26(4):803-12. PubMed ID: 5114819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.